Bayer deal could leapfrog Elanco to become industry leader

PUBLISHED BY
Anna Domanska



TAGS:


3 years ago



THRD_IDMerit_Ad

Square-Add

Elanco Animal Health said on Tuesday it would buy Bayer’s veterinary drugs unit in a deal worth $7.6 billion, creating the second-largest animal health business sector.

The acquisition of Bayer’s animal health unit is subjected to regulatory approval. As a part of the deal, Bayer will receive $5.32 billion in cash, subject to customary purchase price adjustments, and $2.28 billion made up of Elanco Animal Health common shares. The Bayer deal would push Elanco’s gross debt to roughly five times adjust EBITDA after taking into account cost cuts it plans to make through the acquisition of Bayer’s animal health unit.

Bayer deal Elanco industry leader

The Bayer Cross, one of the best-known trademarks in the world, is given a good clean at Cologne-Bonn airport. Photo: Bayer AG

The deal is expected to close by mid-2020, Elanco said.

Company statements on the Elanco – Bayer Merger

Elanco said in a statement the combined organization will “continue to deliver mid-single-digit revenue growth while accelerating the achievement of adjusted gross margin goals and delivering double-digit adjusted EBITDA margin growth.”

Jeffrey N. Simmons, Elanco president and chief executive, said: “The move combines our long-standing focus on the veterinarian while meeting pet owners’ changing expectation of pet care and access to products.”

“The combination with Elanco will give rise to a leading competitor in the animal health industry, benefiting customers, employees and shareholders alike,” said Bayer chief executive Werner Baumann.

The division sells veterinary treatments for both pets and livestock, including the best-selling Advantage treatment for fleas and ticks.

Surpass Zoetis as Industry Leader

Now that the Bayer deal has materialized, more than 40 percent of the combined company’s sales would come from animal health products, a similar proportion to market leader Zoetis.

Bayer Deal Elanco industry leader

The Bayer deal is crucial in Elanco’s effort to become an industry leader in the animal-healthcare sector.

Today’s news should please investors since pet-health has become a hotbed for investment for the past few years. According to a report by Global Market Insights, Inc., global animal-health market is expected to peak $36 billion by 2024. Burgeoning pet adoption across the world, especially in developing countries, is driving the surge in pet-health market growth. With increasing disposable incomes, pet owners would be able to spend more on animal healthcare. Wonder who’s profiting from the trend in pet humanization? Here’s a more detailed post on top companies in animal health.

Anna Domanska
Anna Domanska is an Industry Leaders Magazine author possessing wide-range of knowledge for Business News. She is an avid reader and writer of Business and CEO Magazines and a rigorous follower of Business Leaders.

Leave a Reply

Your email address will not be published.

Recent Posts

Bill Ackman on Inflation: The Fed Will Hike Interest Rates

Bill Ackman on Inflation: The Fed Will Hike Interest Rates

Last month, the hedge fund manager suggested that only aggressive monetary tightening or a collapse in the economy will do the trick. He stated that the markets will recover if the
22 hours ago
Cadillac’s Luxury Electric Vehicle Starts At $300,000

Cadillac’s Luxury Electric Vehicle Starts At $300,000

The Lyriq is the headliner for Cadillac as it is the first of GM’s brands to go all-electric by 2030.The Celestiq will not roll off GM’s usual factories, rather it will be
1 day ago
Juul Products Banned – Will The FDA Win The Battle?

Juul Products Banned – Will The FDA Win The Battle?

In a written statement, FDA Commissioner Robert M. Califf stated, “Today’s action is further progress on the FDA’s commitment to ensuring that all e-cigarette and electronic
3 days ago
The Mark Cuban Cost Plus Drug Company Takes on Big Pharmas

The Mark Cuban Cost Plus Drug Company Takes on Big Pharmas

Commonly used generic drugs are available at a 15% markup, plus a $3 dispensing fee and $5 shipping fee. In an interview with PBS News, Cuban told the host that the Mark Cuban phar
3 days ago
The Brookfield Global Transition Fund Promises Net Zero Returns

The Brookfield Global Transition Fund Promises Net Zero Returns

According to a written statement issued by the company, they have already deployed $2.5 billion to fund decarbonization technologies in the US, the UK, Germany, and North America.
3 days ago
Network Configuration Error Causes Cloudflare Outage Across 19 Locations

Network Configuration Error Causes Cloudflare Outage Across 19 Locations

The Cloudflare outage was most problematic for users of Cloudflare’s DNS lookup service. “Customers attempting to reach Cloudflare sites in impacted regions will observe 50
4 days ago